Utilization Management
Prescription Drug Prior Authorization and Step Therapy Policies for Cascade Select Marketplace Business
Not all medications will be covered on the formulary. Non-formulary medications are subject to the Medical Necessity for Non-Formulary Medications policy. Please consult the formulary to verify coverage.
| Lofexidine PA Policy | Policy |
| Lupus - Benlysta Intravenous PA Policy | Policy |
| Lupus - Benlysta Subcutaneous DQM Policy - Per Days | Policy |
| Lupus - Benlysta Subcutaneous PA Policy | Policy |
| Lupus - Lupkynis PA Policy | Policy |
| Lupus - Saphnelo Intravenous PA Policy | Policy |
| Lupus - Saphnelo Subcutaneous PA Policy | Policy |
| Menkes Disease - Zycubo PA Policy | Policy |
| Metabolic Disorders - Betaine Anhydrous PA Policy | Policy |
| Metabolic Disorders - Betaine Anhydrous PSM Policy | Policy |
| Metabolic Disorders - Carglumic Acid PA Policy | Policy |
| Metabolic Disorders - Dojolvi PA Policy | Policy |
| Metabolic Disorders - Imcivree PA Policy | Policy |
| Metabolic Disorders - Nitisinone Products PA Policy | Policy |
| Metabolic Disorders - Nulibry PA Policy | Policy |
| Metabolic Disorders - Phenylbutyrate Products PSM Policy | Policy |
| Metabolic Disorders - Primary Hyperoxaluria - Oxlumo PA Policy | Policy |
| Metabolic Disorders - Primary Hyperoxaluria - Rivfloza PA Policy | Policy |
| Metabolic Disorders - Tiopronin Products PA Policy | Policy |
| Metabolic Disorders - Tiopronin Products PSM Policy | Policy |
| Metabolic Disorders - Xuriden PA Policy | Policy |
| Metabolic Disorders – Cysteamine Ophthalmic Solution PA Policy | Policy |
| Methotrexate Injection Step Therapy Policy | Policy |
| Migraine - Calcitonin Gene-Related Peptide Inhibitors - Aimovig DQM Policy - Per Days | Policy |
| Migraine - Calcitonin Gene-Related Peptide Inhibitors - Aimovig PA Policy | Policy |
| Migraine - Calcitonin Gene-Related Peptide Inhibitors - Ajovy PA Policy | Policy |
| Migraine - Calcitonin Gene-Related Peptide Inhibitors - Emgality DQM Policy - Per Days | Policy |
| Migraine - Calcitonin Gene-Related Peptide Inhibitors - Emgality PA Policy | Policy |
| Migraine - Calcitonin Gene-Related Peptide Inhibitors - Vyepti PA Policy | Policy |
| Migraine - Elyxyb PA Policy | Policy |
| Migraine - Nurtec ODT PA Policy | Policy |
| Migraine - Qulipta PA Policy | Policy |
| Migraine - Reyvow PA Policy | Policy |
| Migraine - Ubrelvy PA Policy | Policy |
| Migraine - Zavzpret PA Policy | Policy |
| Migraine – Nonsteroidal Anti-Inflammatory Drugs DQM Policy – Per Days | Policy |
| Migraine – Other Medications DQM Policy – Per Days | Policy |
| Migraine – Triptans DQM Policy – Per Days | Policy |
| Migraine Medication Step Therapy Policy | Policy |
| Multiple Sclerosis - CD20-Directed Cytolytic Antibody Infused Products PSM Policy | Policy |
| Multiple Sclerosis - Dalfampridine PSM Policy | Policy |
| Multiple Sclerosis (Injectable - CD20-Directed Cytolytic Antibody) - Kesimpta DQM Policy - Per Days | Policy |
| Multiple Sclerosis (Injectable - CD20-Directed Cytolytic Antibody) - Ocrevus and Ocrevus Zunovo DQM Policy - Per Days | Policy |
| Multiple Sclerosis (Injectable - Other) - Lemtrada DQM Policy - Per Days | Policy |
| Multiple Sclerosis (Injectable - Other) - Lemtrada PA Policy | Policy |
| Multiple Sclerosis (Oral - Fumarate) - Bafiertam PA Policy | Policy |
| Multiple Sclerosis (Oral - Fumarate) - Dimethyl Fumarate PA Policy | Policy |
| Multiple Sclerosis (Oral - Other) - Teriflunomide PA Policy | Policy |
| Multiple Sclerosis (Oral - Sphingosine 1-Phosphate Receptor Modulator) - Mayzent PA Policy | Policy |
| Multiple Sclerosis (Oral - Sphingosine 1-Phosphate Receptor Modulator) - Ponvory DQM Policy - Per Days | Policy |
| Multiple Sclerosis and Crohn's Disease (Injectable - Other) - Natalizumab Products PA Policy | Policy |
| Multiple Sclerosis and Ulcerative Colitis - Zeposia PSM Policy for High Performance Formulary 01.01.26 | Policy |
| Multiple Sclerosis PSM Policy | Policy |
| Muscular Dystrophy - Agamree PA Policy | Policy |
| Muscular Dystrophy - Amondys 45 PA Policy | Policy |
| Muscular Dystrophy - Deflazacort PA Policy | Policy |
| Muscular Dystrophy - Deflazacort PSM Policy | Policy |
| Muscular Dystrophy - Duvyzat PA Policy | Policy |
| Muscular Dystrophy - Exondys 51 PA Policy | Policy |
| Muscular Dystrophy - Gene Therapy - Elevidys PA Policy | Policy |
| Muscular Dystrophy - Viltepso PA Policy | Policy |
| Muscular Dystrophy - Vyondys 53 PA Policy | Policy |
| Nephrology - Filspari PA Policy | Policy |
| Nephrology - Jesduvroq PA Policy | Policy |
| Nephrology - Tarpeyo PA Policy | Policy |
| Nephrology - Trutakna PA Policy | Policy |
| Nephrology - Vafseo PA Policy | Policy |
| Nephrology - Vanrafia PA Policy | Policy |
| Nephrology - Voyxact PA Policy | Policy |
| Nephrology - Xphozah PA Policy | Policy |
| Neurology - Brineura PA Policy | Policy |
| Neurology - Daybue PA Policy | Policy |
| Neurology - Edaravone Products PA Policy | Policy |
| Neurology - Gene Therapy - Kebilidi PA Policy | Policy |
| Neurology - Gene Therapy - Lenmeldy PA Policy | Policy |
| Neurology - Gene Therapy - Skysona PA Policy | Policy |
| Neurology - Imaavy PA Policy | Policy |
| Neurology - Lyrica CR PA with Step Therapy Policy | Policy |
| Neurology - Qalsody PA Policy | Policy |
| Neurology - Riluzole Products PA Policy | Policy |
| Neurology - Rystiggo PA Policy | Policy |
| Neurology - Skyclarys PA Policy | Policy |
| Neurology - Tonmya PA with Step Therapy Policy | Policy |
| Neurology - Vyvgart Hytrulo PA Policy | Policy |
| Neurology - Vyvgart Intravenous PA Policy | Policy |
| Niemann-Pick disease type C - Aqneursa PA Policy | Policy |
| Niemann-Pick Disease Type C - Miplyffa PA Policy | Policy |
| Non-Steroidal Mineralocorticoid Receptor Antagonist - Kerendia PA Policy | Policy |
| Nonsteroidal Anti-Inflammatory Drug - Tivorbex DQM Policy - Per Rx | Policy |
| Nonsteroidal Anti-Inflammatory Drugs Step Therapy Policy | Policy |
| Nuedexta PA Policy | Policy |
| Oncology - (Oral - Epidermal Growth Factor Receptor Inhibitor) - Erlotinib DQM Policy - Per Rx | Policy |
| Oncology - Abiraterone Acetate PSM Policy | Policy |
| Oncology - Balversa PA Policy | Policy |
| Oncology - Bexarotene (Oral) PA Policy | Policy |
| Oncology - Bexarotene (Oral) PSM Policy | Policy |
| Oncology - Bexarotene (Topical) PSM Policy | Policy |
| Oncology - Bosulif DQM Policy - Per Rx | Policy |
| Oncology - Cabometyx DQM Policy - Per Rx | Policy |
| Oncology - Capecitabine DQM Policy - Per Rx | Policy |